SCHEMBL22492228

SCHEMBL22492228

CN(C(=O)O)c1cccc(SCc2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
KMT2A Q03164 4/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41
MEN1 O00255 2/20 0.41
KDM4E B2RXH2 2/20 0.40
DAO P14920 1/20 0.40
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
SLC6A4 P31645 1/20 0.40
MCL1 Q07820 1/20 0.40
BCL2A1 Q16548 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
POLB P06746 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
PTPRC P08575 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24448907 0.83 HTR2C (0.48) KMT2AL3MBTL1MAOAMAOBMEN1
SCHEMBL3372867 0.78 MAOA (0.47) KMT2AMAOAMAOBMEN1KDM4E
SCHEMBL5344206 0.78 GRIN2D (0.49) KMT2AMEN1MAPTPOLBALDH1A1
SCHEMBL1322419 0.77 MAOB (0.51) L3MBTL1MAOAMAOBSLC6A4ALDH1A1
SCHEMBL7139139 0.75 HAO1 (0.46) KMT2AMEN1KDM4EMCL1BCL2A1
SCHEMBL18039236 0.74 CRHBP (0.47) CRHBPCRHR2KMT2AL3MBTL1MEN1
SCHEMBL10718327 0.73 AKR1B1 (0.53) KMT2AMAOAMAOBMEN1KDM4E
SCHEMBL3889076 0.73 APEX1 (0.65) KMT2AMAOAMAOBMEN1KDM4E
SCHEMBL30198674 0.73 APEX1 (0.65) KMT2AMAOAMAOBMEN1KDM4E
SCHEMBL16274690 0.73 CRHBP (0.46) CRHBPCRHR2KMT2AL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. (US) 2023-11-09 US disclosed
US-11685732-B2 MYST family histone acetyltransferase inhibitors Epizyme, Inc. (US) 2023-06-27 US disclosed
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. 2022-05-26 US disclosed
EP-3716964-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. (US) 2020-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A CRHBP 2483/4885CRHR2 4432/4885KMT2A 33/4885
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A CRHBP 2483/4885CRHR2 4432/4885KMT2A 33/4885
US-11685732-B2 MYST family histone acetyltransferase inhibitors EP300, KAT2A, KAT6A CRHBP 2483/4885CRHR2 4432/4885KMT2A 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.